@techinasia.com 8 months ago
In 50 Words: Rakuten founder prioritizes US cancer startup amid business losses
@xconomy.com 3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com 4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@techcrunch.com 6 years ago
Ourotech is taking the guesswork out of cancer treatment